Star Sports Medicine Buys Back 2,500 H-Shares for HK$0.17 Million, Treasury Stock Rises to 64,200

Bulletin Express10-16

Star Sports Medicine Co., Ltd. disclosed that on 16 October 2026 the company repurchased 2,500 H-shares on the Hong Kong Stock Exchange, paying an aggregate HK$168,307.50.

The buyback was executed within a price band of HK$66.75 to HK$68.35 per share, with a volume-weighted average cost of HK$67.323. The repurchased shares are being held as treasury stock; none were cancelled.

Key share data after the transaction: • Issued shares in circulation (excluding treasury shares): 54.77 million. • Treasury shares on hand: 64,200. • Total issued shares (including treasury): 54.83 million.

Utilisation of the current mandate remains low. Since shareholders granted a 10% repurchase mandate on 26 June 2026—authorising up to 5.48 million shares—Star Sports Medicine has repurchased 64,200 shares, equivalent to 0.12 % of the issued share capital on the mandate date.

The company confirmed that the repurchase complied with Hong Kong Main Board Listing Rules. A 30-day moratorium on new share issues or further sales of treasury shares runs through 15 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment